Aptamer Group PLC Total Assets
Aptamer Group PLC total assets. Based on the latest financial reports, Aptamer Group PLC (APTA) holds total assets worth GBX2.83 Million GBX (≈ $344.82 USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Aptamer Group PLC stock valuation for the company's overall valuation and market capitalisation.
Total Assets of Aptamer Group PLC (2019–2025)
Total assets of Aptamer Group PLC from 2019 to 2025. This chart illustrates how Aptamer Group PLC's total assets have evolved over time, based on quarterly financial data. See current stock price of Aptamer Group PLC for real-time trading data and today's change.
Aptamer Group PLC - Asset Composition Analysis
Aptamer Group PLC Total Assets Breakdown (June 2025)
Aptamer Group PLC total assets breakdown as of June 2025. Aptamer Group PLC's total assets of GBX2.83 Million consist of 64.3% current assets and 35.7% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 37.4% |
| Accounts Receivable | GBX532.00K | 18.8% |
| Inventory | GBX80.00K | 2.8% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX225.00K | 7.9% |
| Goodwill | GBX0.00 | 0.0% |
Asset Composition Trend (2019–2025)
This chart illustrates how Aptamer Group PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore APTA working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Aptamer Group PLC's current assets represent 64.3% of total assets in 2025, a decrease from 88.4% in 2019.
- Cash Position: Cash and equivalents constituted 37.4% of total assets in 2025, down from 52.1% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, an increase from 1.0% in 2019.
- Asset Diversification: The largest asset category is accounts receivable at 18.8% of total assets.
Aptamer Group PLC Competitors by Total Assets
Key competitors of Aptamer Group PLC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Samsung Biologics Co Ltd
KO:207940
|
Korea | ₩12.65 Trillion |
|
Verona Pharma plc
F:I9SA
|
Germany | €572.87 Million |
|
Asymchem Laboratories Tian Jin Co Ltd
SHE:002821
|
China | CN¥20.70 Billion |
|
Immunovant Inc
NASDAQ:IMVT
|
USA | $852.49 Million |
|
Shanghai Allist Pharmaceuticals Co. Ltd. A
SHG:688578
|
China | CN¥8.59 Billion |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.99 Billion |
|
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252
|
China | CN¥37.46 Billion |
|
Amicus Therapeutics Inc
NASDAQ:FOLD
|
USA | $949.87 Million |
Aptamer Group PLC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.55 | 1.27 | 2.58 |
| Quick Ratio | 1.48 | 1.17 | 2.45 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX647.00K | GBX340.00K | GBX755.23K |
Aptamer Group PLC - Advanced Valuation Insights
This section examines the relationship between Aptamer Group PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 17.56 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | 2.3% |
| Total Assets | GBX2.83 Million |
| Market Capitalization | $93.52K USD |
Valuation Analysis
Below Book Valuation: The market values Aptamer Group PLC's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Aptamer Group PLC's assets grew by 2.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Aptamer Group PLC (2019–2025)
The table below shows the annual total assets of Aptamer Group PLC from 2019 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | GBX2.83 Million ≈ $344.82 |
+2.35% |
| 2024-06-30 | GBX2.77 Million ≈ $336.91 |
+0.58% |
| 2023-06-30 | GBX2.75 Million ≈ $334.96 |
-76.10% |
| 2022-06-30 | GBX11.52 Million ≈ $1.40K |
+458.14% |
| 2021-06-30 | GBX2.06 Million ≈ $251.13 |
+48.51% |
| 2020-03-31 | GBX1.39 Million ≈ $169.09 |
-0.53% |
| 2019-03-31 | GBX1.40 Million ≈ $169.99 |
-- |
About Aptamer Group PLC
Aptamer Group PLC, together with its subsidiaries, provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers, which can bind to target molecules. Its platform is used in research reagent and … Read more